Amyloid-<wbr/>? Monoclonal Antibody (Clone 6C3, MOAB-<wbr/>2)

Amyloid-? Monoclonal Antibody (Clone 6C3, MOAB-2)

CAT N°: 11610
Price:

€513.00 €436.05

Amyloid plaques composed primarily of the 42 amino acid form of amyloid-? peptide (A?42) are a hallmark of Alzheimer’s disease (AD). However, the roles of the various amyloid ? peptide(s), especially A?42, related to the neurotoxicity characteristic of AD remains unclear. A major hindrance to evaluating the role of A? in AD pathology has been the availability of anti-A? antibodies to selectively detect A? versus amyloid precursor protein (APP), A?40 versus A?42, and specific conformations of the peptide, particularly oligomeric forms. MOAB-2 (mouse IgG2b) is a pan-specific antibody specific to A? (residues 1-4) that differentiates intracellular A? from APP. MOAB-2 does not detect APP in cell culture media/lysates or in brain homogenates from transgenic mice expressing 5 familial AD mutation (5xFAD mice). Intraneuronal A? was confirmed by co-localization of MOAB-2 immunoreactivity with C-terminal antibodies specific for A?40 and A?42, and with cathepsin-D, a lysosomal marker. Additionally, MOAB-2 demonstrates strong intraneuronal and extra-cellular immunoreactivity in 5xFAD and 3xTg mouse brain tissues.{20683}

Territorial Availability: Available through Bertin Technologies only in France

  • Correlated keywords
    • A? amyloid beta amyloid-beta amyloid .beta. MOAB2 MOAB 2 A?-42 A? 42 A?-40 A? 40 alzheimer’s diseaseHEK 5xFAD 3xTg HEK-APPSwe FAD
  • Product Overview:
    Amyloid plaques composed primarily of the 42 amino acid form of amyloid-? peptide (A?42) are a hallmark of Alzheimer’s disease (AD). However, the roles of the various amyloid ? peptide(s), especially A?42, related to the neurotoxicity characteristic of AD remains unclear. A major hindrance to evaluating the role of A? in AD pathology has been the availability of anti-A? antibodies to selectively detect A? versus amyloid precursor protein (APP), A?40 versus A?42, and specific conformations of the peptide, particularly oligomeric forms. MOAB-2 (mouse IgG2b) is a pan-specific antibody specific to A? (residues 1-4) that differentiates intracellular A? from APP. MOAB-2 does not detect APP in cell culture media/lysates or in brain homogenates from transgenic mice expressing 5 familial AD mutation (5xFAD mice). Intraneuronal A? was confirmed by co-localization of MOAB-2 immunoreactivity with C-terminal antibodies specific for A?40 and A?42, and with cathepsin-D, a lysosomal marker. Additionally, MOAB-2 demonstrates strong intraneuronal and extra-cellular immunoreactivity in 5xFAD and 3xTg mouse brain tissues.{20683}

We also advise you

Any project? Any challenge? We are in!
Contact us

Headquarters:
Parc d’activités du Pas du Lac
10 bis avenue Ampère

78180 Montigny le Bretonneux
France

Call us
Information
My account
Follow us

Copyright © 2024 BERTIN BIOREAGENT. All rights reserved | Terms & conditions

Secure payment
Subscribe to our newsletter